NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . November 2nd, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Vaccine Week | Other Publications

Springer - Elderly immune system needs a boost

Cancer Vaccines - Research on cancer vaccines detailed by P. Basu and co-authors

Cancer Gene Therapy Vaccines - Researchers from School of Medicine publish findings in cancer gene therapy vaccines

Cancer Vaccines - Data on cancer vaccines detailed by researchers at University of Tubingen

Cancer Vaccines - Data on cancer vaccines reported by researchers at California Pacific Medical Center

Cancer Vaccines - Scientists at Kurume University discuss research in cancer vaccines

Cancer Vaccines - Scientists at Memorial Sloan Kettering Cancer Center report research in cancer vaccines

Influenza Vaccines - Data on influenza vaccines described by researchers at Medical University of Vienna

Advaxis, Inc. - Advaxis Appoints Christopher Duignan Senior Vice President, Finance

Argos Therapeutics - Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis(TM) HIV Program at the AIDS Vaccine 2009 Conference

Arthritis - CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis

Bristol-Myers Squibb Company - ORENCIA(R) abatacept Demonstrated Sustained Clinical Response in a Study of Adult Patients with Moderate to Severe Early Rheumatoid Arthritis Less Than Two Years Duration

Cancer Gene Therapy - HealthWell Foundation(R) Appoints New Executive Director

Cancer Vaccines - =?ISO-8859-1?Q?FDA_APPROVES_CERVARIX,_GLAXOSMIT? =?ISO-8859-1?Q?

Cancer Vaccines - CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women

Cancer Vaccines - Karmanos Cancer Institute Immunology Researcher Obtains Nearly $1 Million National Institutes of Health Grant

Cancer Vaccines - Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain

Entest BioMedical Inc. - Entest BioMedical Announces Intent to Acquire Cancer Research Company Therinject LLC

MERCK & CO., Inc. - CDC Advisory Committee on Immunization Practices Votes for Permissive Use and for Vaccines for Children Funding for GARDASIL(R) for Boys and Young Men

Research and Markets - This Latest Chile Pharmaceuticals and Healthcare Report Provides Independent Forecasts and Competitive Intelligence On the Industry

TechnoVax, Inc. - TechnoVax Receives $2.9 Million Grant for Flu and Influenza Virus-Like Particle VLP Vaccine Program



Return to Top of Page

-----------------------
PR Login